Evidence map›Paper›PMID 26325373›Full record

ArticlePloS one2015

The RNA Binding Protein Igf2bp1 Is Required for Zebrafish RGC Axon Outgrowth In Vivo.

John A Gaynes, Hideo Otsuna, Douglas S Campbell, John P Manfredi, Edward M Levine, Chi-Bin Chien

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Tagged actin mRNA dysregulation in IGF2BP1[Formula: see text] mice.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

John A GaynesProgram in Neuroscience, University of Utah Medical Center, Salt Lake City, Utah, United States of America; Department of Neurobiology and Anatomy, University of Utah Medical Center, Salt Lake City, Utah, United States of America; Department of Ophthalmology/Visual Sciences, John A. Moran Center, University of Utah Medical Center, Salt Lake City, Utah, United States of America.
Hideo OtsunaDepartment of Neurobiology and Anatomy, University of Utah Medical Center, Salt Lake City, Utah, United States of America.
Douglas S CampbellDepartment of Neurobiology and Anatomy, University of Utah Medical Center, Salt Lake City, Utah, United States of America; Max Planck Institute for Brain Research, Frankfurt am Main, Germany.
John P ManfrediSfida BioLogic, Inc., Salt Lake City, Utah, United States of America.
Edward M LevineProgram in Neuroscience, University of Utah Medical Center, Salt Lake City, Utah, United States of America; Department of Neurobiology and Anatomy, University of Utah Medical Center, Salt Lake City, Utah, United States of America; Department of Ophthalmology/Visual Sciences, John A. Moran Center, University of Utah Medical Center, Salt Lake City, Utah, United States of America.
Chi-Bin ChienProgram in Neuroscience, University of Utah Medical Center, Salt Lake City, Utah, United States of America; Department of Neurobiology and Anatomy, University of Utah Medical Center, Salt Lake City, Utah, United States of America.
University of Utah · USMax Planck Institute for Brain Research · DE

Funding

University of Utah, Core Vision Research GrantP30EY014800 · NEI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Bryan William Jones · 2005 to 2026
$14.6M
Vsx2 Dependent Regulation of Retinal Progenitor Cell PropertiesR01EY013760 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI LEVINE, EDWARD M · 2003 to 2024
$6.9M
RETINAL AXON PATHFINDING MUTANTS IN ZEBRAFISHR01EY012873 · NEI · UNIVERSITY OF UTAH · PI VETTER, MONICA L · 2000 to 2011
$4.0M
NEI NIH HHS EY012873NEI NIH HHS EY013760NEI NIH HHS P30 EY014800NEI NIH HHS P30-EY014800NEI NIH HHS R01 EY012873NEI NIH HHS R01 EY013760
6 · The paper itself

Abstract

Attractive growth cone turning requires Igf2bp1-dependent local translation of β-actin mRNA in response to external cues in vitro. While in vivo studies have shown that Igf2bp1 is required for cell migration and axon terminal branching, a requirement for Igf2bp1 function during axon outgrowth has not been demonstrated. Using a timelapse assay in the zebrafish retinotectal system, we demonstrate that the β-actin 3'UTR is sufficient to target local translation of the photoconvertible fluorescent protein Kaede in growth cones of pathfinding retinal ganglion cells (RGCs) in vivo. Igf2bp1 knockdown reduced RGC axonal outgrowth and tectal coverage and retinal cell survival. RGC-specific expression of a phosphomimetic Igf2bp1 reduced the density of axonal projections in the optic tract while sparing RGCs, demonstrating for the first time that Igf2bp1 is required during axon outgrowth in vivo. Therefore, regulation of local translation mediated by Igf2bp proteins may be required at all stages of axon development.

Indexed as

ActinsAnimalsAxonsGene Knockdown TechniquesRetinal Ganglion CellsRNA-Binding ProteinsZebrafishZebrafish ProteinsActinsIgf2bp1 protein, zebrafishRNA-Binding ProteinsZebrafish Proteins

Identifiers

PMID26325373
PMCPMC4556669
OpenAlexW2141316727

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.